{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:43:48Z","timestamp":1791319428542,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd015033","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000}}],"reference-count":141,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015033.pub2","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:42:11Z","timestamp":1729060931000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vitamin E for people with non-alcoholic fatty liver disease"],"prefix":"10.1002","volume":"2024","author":[{"given":"Hongzhu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyong","family":"Deng","sequence":"additional","affiliation":[{"name":"EBM Center of TCM; Shanghai University of Traditional Chinese Medicine; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[{"name":"Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujin","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai University of Traditional Chinese Medicine; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Bjelakovic","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterohepatology; University Clinical Centre Nis; Nis Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[{"name":"Shanghai University of Traditional Chinese Medicine; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0002|cit2","first-page":"S0168","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"23","author":"Rinella","year":"2023","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"106175","DOI":"10.1016\/j.cct.2020.106175","article-title":"The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease","volume":"98","author":"Hardy","year":"2020","journal-title":"Contemporary Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2024","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1074\u201387","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features: insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatology Research"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4254\/wjh.v10.i8.530","article-title":"Current status of imaging in nonalcoholic fatty liver disease","volume":"10","author":"Li","year":"2018","journal-title":"World Journal of Hepatology"},{"issue":"10290","key":"10.1002\/14651858.CD015033.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jpeds.2012.08.043","article-title":"Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010","volume":"162","author":"Welsh","year":"2013","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic fatty liver disease: a pathogenic duo","volume":"34","author":"Williams","year":"2013","journal-title":"Endocrine Reviews"},{"issue":"4","key":"10.1002\/14651858.CD015033.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD015033.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/apt.17096","article-title":"Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021","volume":"56","author":"Li","year":"2022","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2017.08.001","article-title":"Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"22","author":"Younossi","year":"2018","journal-title":"Clinical Liver Disease"},{"issue":"10","key":"10.1002\/14651858.CD015033.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes","volume":"62","author":"Cholankeril","year":"2017","journal-title":"Digestive Diseases and Sciences"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD015033.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD015033.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.30577","article-title":"The intestinal microbiome, plasma metabolome, and liver transcriptome: a conspiracy driving hepatic steatosis","volume":"70","author":"Mehal","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.31229","article-title":"Genetic pathways in nonalcoholic fatty liver disease: insights from systems biology","volume":"72","author":"Sookoian","year":"2020","journal-title":"Hepatology"},{"issue":"17","key":"10.1002\/14651858.CD015033.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2023.17935","article-title":"Diagnosis and management of nonalcoholic fatty liver disease","volume":"330","author":"Leung","year":"2023","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0024|cit24","first-page":"3118","article-title":"Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study","volume":"19","author":"Aller","year":"2015","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1365-2036.2006.03161.x","article-title":"Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease","volume":"24","author":"Nobili","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"18","key":"10.1002\/14651858.CD015033.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"E870","DOI":"10.3390\/nu9080870","article-title":"Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study","volume":"9","author":"Abenavoli","year":"2017","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0029|cit29","first-page":"12","article-title":"N-acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease","volume":"10","author":"Khoshbaten","year":"2010","journal-title":"Hepatitis Monthly"},{"issue":"3","key":"10.1002\/14651858.CD015033.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007749.pub2","article-title":"Antioxidant supplements for liver diseases","author":"Bjelakovic","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1458","key":"10.1002\/14651858.CD015033.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.56.1458.650","article-title":"On the existence of a hitherto unrecognized dietary factor essential for reproduction","volume":"56","author":"Evans","year":"1922","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD015033.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000343106","article-title":"A history of vitamin E","volume":"61","author":"Niki","year":"2012","journal-title":"Annals of Nutrition and Metabolism"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.09.017","article-title":"Vitamin E: emerging aspects and new directions","volume":"102","author":"Galli","year":"2017","journal-title":"Free Radical Biology & Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4236\/ojgas.2014.45030","article-title":"Effect of vitamin E and alpha lipoic acid in nonalcoholic fatty liver disease: a randomized, placebo-controlled, open-label, prospective clinical trial (VAIN trial)","volume":"4","author":"Basu","year":"2014","journal-title":"Open Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1002\/14651858.CD015033.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013157.pub2","article-title":"Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis","author":"Komolafe","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD015033.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1139\/apnm-2016-0689","article-title":"Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial","volume":"42","author":"Z\u00f6hrer","year":"2017","journal-title":"Applied Physiology, Nutrition and Metabolism"},{"issue":"11","key":"10.1002\/14651858.CD015033.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD015033.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3748\/wjg.14.1598","article-title":"Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children","volume":"14","author":"Wang","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all cause mortality","volume":"142","author":"Pastor-Barriuso","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD015033.pub2-BIB0042|cit42","first-page":"1095","article-title":"Therapeutic effects of vitamin E supplementation in liver diseases and transplantation","volume":"3","author":"Wittlin","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"101710","DOI":"10.1016\/j.redox.2020.101710","article-title":"Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis","volume":"37","author":"Podszun","year":"2020","journal-title":"Redox Biology"},{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00204-008-0394-7","article-title":"Effect of alpha-tocopherol on carbon tetrachloride intoxication in the rat liver","volume":"83","author":"Iida","year":"2009","journal-title":"Archives of Toxicology"},{"issue":"9","key":"10.1002\/14651858.CD015033.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/00365520903114912","article-title":"Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice","volume":"44","author":"Nan","year":"2009","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1258\/ebm.2009.009122","article-title":"Vitamin E regulates adipocytokine expression in a rat model of dietary-induced obesity","volume":"235","author":"Shen","year":"2010","journal-title":"Experimental Biology and Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/oby.2007.546","article-title":"Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects","volume":"15","author":"Sutherland","year":"2007","journal-title":"Obesity"},{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11745-007-3043-7","article-title":"Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane","volume":"42","author":"Yoshida","year":"2007","journal-title":"Lipids"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004996.pub3","article-title":"Antioxidant supplements for non-alcoholic fatty liver disease and\/or steatohepatitis","author":"Lirussi","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/postgradmedj-2018-136364","article-title":"Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials","volume":"95","author":"Amanullah","year":"2019","journal-title":"Postgraduate Medical Journal"},{"issue":"7-8","key":"10.1002\/14651858.CD015033.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.nut.2014.11.018","article-title":"Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials","volume":"31","author":"Sato","year":"2015","journal-title":"Nutrition"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0053|cit53","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0054|cit54","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2) database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1572-0241.2007.01520.x","article-title":"Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD)","volume":"102","author":"Poonam","year":"2007","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015033.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0058|cit58","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0060|cit60","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0061|cit61","first-page":"n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0062|cit62","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0063|cit63","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0064|cit64","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0065|cit65","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0066|cit66","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0067|cit67","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0068|cit68","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0069|cit69","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"7066","key":"10.1002\/14651858.CD015033.pub2-BIB0070|cit70","first-page":"1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1966","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0072|cit72","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"7211","key":"10.1002\/14651858.CD015033.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0074|cit74","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD015033.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"7109","key":"10.1002\/14651858.CD015033.pub2-BIB0076|cit76","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0077|cit77","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13643-018-0770-1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jclinepi.2018.10.009","article-title":"Increased risks for random errors are common in outcomes graded as high certainty of evidence","volume":"106","author":"Gartlehner","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0082|cit82","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017 Available from ctu.dk\/tsa\/learn-more"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0083|cit83","unstructured":"TSA - Trial Sequential Analysis Copenhagen Trial Unit 2021"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0087|cit87","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD015033.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1024\/0300-9831\/a000086","article-title":"Therapeutic eIect of metformin and vitamin E versusprescriptive diet in obese adolescents with fatty liver","volume":"81","author":"Akcam","year":"2011","journal-title":"International Journal for Vitamin and Nutrition Research"},{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MEG.0000000000001369","article-title":"Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial","volume":"31","author":"Anushiravani","year":"2019","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for non-alcoholic steatohepatitis in patients with type 2 diabetes: a randomised controlled trial","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015033.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2337\/db18-1223-P","article-title":"Role of vitamin E for the treatment of nonalcoholic steatohepatitis (NASH) in patients with T2DM - a randomized, controlled trial","volume":"67","author":"Bril","year":"2018","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0093|cit93","first-page":"14","article-title":"Effect of tocotrienol on liver enzymes, fatty liver and liver stiffness in people with type 2 diabetes and NAFLD: a pilot study based on biochemical and transient elastography parameters","volume":"121","author":"Devarajan","year":"2023","journal-title":"Journal of the Indian Medical Association"},{"issue":"12","key":"10.1002\/14651858.CD015033.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.cgh.2006.09.025","article-title":"Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis","volume":"4","author":"Dufour","year":"2006","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1478-3231.2009.02037.x","article-title":"Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis","volume":"29","author":"Balmer","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/1735-1995.193178","article-title":"Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double\u2011blind, placebo\u2011controlled trial","volume":"21","author":"Ekhlasi","year":"2016","journal-title":"Journal of Research in Medical Sciences"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0097|cit97","first-page":"278","article-title":"Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease","volume":"16","author":"Ekhlasi","year":"2017","journal-title":"EXCLI Journal : Experimental and Clinical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17795\/compreped-6249","article-title":"Lifestyle intervention and vitamin E therapy in obese children with nonalcoholic fatty liver disease","volume":"4","author":"Ghergherehchi","year":"2013","journal-title":"Journal of Comprehensive Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD015033.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"16","key":"10.1002\/14651858.CD015033.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1475-2891-12-166","article-title":"Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial","volume":"12","author":"Magosso","year":"2013","journal-title":"Nutrition Journal"},{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"101398","DOI":"10.1016\/j.jceh.2024.101398","article-title":"A prospective randomized comparative four arm intervention study of efficacy and safety of saroglitazar and vitamin E in patients with non-alcoholic fatty liver disease","volume":"14","author":"Mir","year":"2024","journal-title":"Journal of Clinical and Experimental Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0103|cit103","first-page":"S52","article-title":"A prospective randomized comparative four arm intervention study of efficacy and safety of saroglitazar and vitamin E in patients with non-alcoholic fatty liver disease\/ non-alcoholic steatohepatitis - an interim analysis","volume":"42","author":"Mir","year":"2023","journal-title":"Indian Journal of Gastroenterology"},{"issue":"140","key":"10.1002\/14651858.CD015033.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"232","DOI":"10.30699\/jambs.30.140.232","article-title":"Comparison of the therapeutic effects of melatonin, metformin and vitamin E on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"30","author":"Hajiagha Mohammadi","year":"2022","journal-title":"Journal of Advances in Medical and Biomedical Research"},{"issue":"11-12","key":"10.1002\/14651858.CD015033.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1365-2036.2006.03161.x","article-title":"Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease","volume":"24","author":"Nobili","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD015033.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.dld.2020.09.021","article-title":"Antioxidant activity of hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD","volume":"53","author":"Mosca","year":"2021","journal-title":"Digestive and Liver Disease"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.22336","article-title":"Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"102494","DOI":"10.1016\/j.ctim.2020.102494","article-title":"Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial","volume":"52","author":"Pervez","year":"2020","journal-title":"Complementary Therapies in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5152\/tjg.2018.17297","article-title":"Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease","volume":"29","author":"Pervez","year":"2018","journal-title":"Turkish Journal of Gastroenterology"},{"issue":"18","key":"10.1002\/14651858.CD015033.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design","volume":"30","author":"Chalasani","year":"2009","journal-title":"Contemporary Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hep4.1680","article-title":"Relationship of ELF and PIIINP with liver histology and response to vitamin E or pioglitazone in the PIVENS Trial","volume":"5","author":"Gawrieh","year":"2021","journal-title":"Hepatology Communications"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/apt.12352","article-title":"Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis","volume":"38","author":"Hoofnagle","year":"2013","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD015033.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep.25805","article-title":"Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study","volume":"56","author":"Bell","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0115|cit115","first-page":"48","article-title":"Vitamin E treatment in pediatric obesity-related liver disease: a randomized study","volume":"38","author":"Vajro","year":"2004","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/nu9080870","article-title":"Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study","volume":"9","author":"Abenavoli","year":"2017","journal-title":"Nutrients"},{"issue":"8","key":"10.1002\/14651858.CD015033.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.sjbs.2020.04.037","article-title":"The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease","volume":"27","author":"Afsharinasab","year":"2020","journal-title":"Saudi Journal of Biological Sciences"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"8742075","DOI":"10.1155\/2019\/8742075","article-title":"Evaluation of the effect derived from silybin with vitamin d and vitamin E administration on clinical, metabolic, endothelial dysfunction, oxidative stress parameters, and serological worsening markers in nonalcoholic fatty liver disease patients","volume":"2019","author":"Federico","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"4","key":"10.1002\/14651858.CD015033.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3325\/cmj.2016.57.331","article-title":"Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial","volume":"57","author":"Ebrahimi-Mameghani","year":"2016","journal-title":"Croatian Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD015033.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.clnu.2016.07.004","article-title":"Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: beneficial effects of supplementation with microalgae Chlorella vulgaris: a double-blind placebo-controlled randomized clinical trial","volume":"36","author":"Ebrahimi-Mameghani","year":"2017","journal-title":"Clinical Nutrition"},{"issue":"23","key":"10.1002\/14651858.CD015033.pub2-BIB0121|cit121","first-page":"7449","article-title":"A randomized controlled trial comparing the effects of vitamin E, ursodeoxycholic acid and pentoxifylline on Egyptian non-alcoholic steatohepatitis patients","volume":"25","author":"Fouda","year":"2021","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-013-0136-3","article-title":"Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose","volume":"34","author":"Han","year":"2014","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2003.50316","article-title":"Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E","volume":"38","author":"Kugelmas","year":"2003","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD015033.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1002\/ptr.7279","article-title":"The effects of co-administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: a randomized clinical trial","volume":"35","author":"Majnooni","year":"2021","journal-title":"Phytotherapy Research"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0125|cit125","unstructured":"An investigator initiated prospective, four arms randomized comparative study of efficacy and safety of saroglitazar, vitamin E and life style modification in patients with nonalcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH) clinicaltrials.gov\/ct2\/show\/NCT04193982"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0126|cit126","unstructured":"Interest in \"Combo\" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement (ICAN) clinicaltrials.gov\/ct2\/show\/NCT04781933"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD015033.pub2-BIB0127|cit127","first-page":"28","article-title":"Vitamin E and non-alcoholic fatty liver disease","volume":"26","author":"Palamaru","year":"2017","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"102866","DOI":"10.1016\/j.ctim.2022.102866","article-title":"Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized double-blind active-controlled trial","volume":"70","author":"Pervez","year":"2022","journal-title":"Complementary Therapies in Medicine"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"101710","DOI":"10.1016\/j.redox.2020.101710","article-title":"Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis","volume":"37","author":"Podszun","year":"2020","journal-title":"Redox Biology"},{"issue":"3","key":"10.1002\/14651858.CD015033.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/19390211.2021.1874587","article-title":"The effects of vitamin E, silymarin and carnitine on the metabolic abnormalities associated with nonalcoholic liver disease","volume":"19","author":"Poulos","year":"2022","journal-title":"Journal of Dietary Supplements"},{"issue":"7","key":"10.1002\/14651858.CD015033.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"e0133496","DOI":"10.1371\/journal.pone.0133496","article-title":"Fish oil supplements lower serum lipids and glucose in correlation with a reduction in plasma fibroblast growth factor 21 and prostaglandin E2 in nonalcoholic fatty liver disease associated with hyperlipidemia: a randomized clinical trial","volume":"10","author":"Qin","year":"2015","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1002\/14651858.CD015033.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3748\/wjg.14.1598","article-title":"Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children","volume":"14","author":"Wang","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD015033.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cpdd.790","article-title":"Pharmacokinetics and pharmacodynamics of ursodeoxycholic acid in an overweight population with abnormal liver function","volume":"10","author":"Yoon","year":"2021","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0134|cit134","first-page":"81","article-title":"Comparative analysis of efficiency of ursodeoxycholic acid and combination of vitamin E and vitamin C in treatment of non-diabetic nonalcoholic steatohepatitis","volume":"288","author":"Barbakadze","year":"2019","journal-title":"Georgian Medical News"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4236\/ojgas.2014.45030","article-title":"Effect of vitamin E and alpha lipoic acid in nonalcoholic fatty liver disease: a randomized, placebo-controlled, open-label, prospective clinical trial (VAIN trial)","volume":"4","author":"Basu","year":"2014","journal-title":"Open Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD015033.pub2-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015033","article-title":"Vitamin E for people with non-alcoholic fatty liver disease","author":"Wen","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015033.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"175628482097491","DOI":"10.1177\/1756284820974917","article-title":"The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"13","author":"Abdel-Maboud","year":"2020","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD015033.pub2-BIB0138|cit138","first-page":"e32764","article-title":"Effect of vitamin E on clinical outcomes in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"14","author":"Karedath","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1002\/14651858.CD015033.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"101530","DOI":"10.1016\/j.clinre.2020.08.008","article-title":"Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysis","volume":"45","author":"Lin","year":"2021","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD015033.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jgh.15221","article-title":"Systematic review with meta-analysis: the effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease","volume":"36","author":"Vadarlis","year":"2021","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"17","key":"10.1002\/14651858.CD015033.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3390\/nu15173733","article-title":"The effect of vitamin E supplementation on serum aminotransferases in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"15","author":"Vogli","year":"2023","journal-title":"Nutrients"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T10:50:06Z","timestamp":1767696606000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015033.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":141,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015033.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}